EGFR and nasopharyngeal carcinoma: As is the situation for molecular targeted drugs, EGFR-targeted therapy has been anticipated to be effective for nasopharyngeal cancer, and drugs that are specific to nasopharyngeal cancer (e.g., nimotuzumab) are being investigated [75].